Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis.
Takasaki K, Miyamoto M, Takano M, Soyama H, Aoyama T, Matsuura H, Kato K, Sakamoto T, Kuwahara M, Iwahashi H, Ishibashi H, Yoshikawa T, Furuya K.
Takasaki K, et al. Among authors: matsuura h.
Cancer Chemother Pharmacol. 2018 May;81(5):809-814. doi: 10.1007/s00280-018-3552-5. Epub 2018 Mar 2.
Cancer Chemother Pharmacol. 2018.
PMID: 29500481